FDA Inspection 583274 — Novo Nordisk A/S
The FDA completed an inspection of Novo Nordisk A/S on May 13, 2009 in Bagsvard. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 13, 2009
- Fiscal Year
- 2009
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Bagsvard (Denmark)
Additional Details
Postmarket Adverse Drug Experience (PADE)